Literature DB >> 25539795

Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case-control study in normal and diabetic pregnancy.

Sandro Gerli1, Alessandro Favilli, Annalisa Brozzetti, Elisabetta Torlone, Brunella Pugliese, Silvia Pericoli, Vittorio Bini, Alberto Falorni.   

Abstract

To assess if anti-mullerian hormone (AMH) concentrations decrease during the third trimester of pregnancy and puerperium and whether this is correlated to gestational diabetes mellitus (GDM). AMH serum concentrations were determined by ELISA, with lowest detection limit of 0.08 ng/ml, during the third trimester of pregnancy and puerperium in 34 patients with GDM and in 32 healthy control pregnant women. Three blood samples were collected at 28-32, 34-36 weeks' gestation and 40 days after delivery, respectively. No differences in AMH concentration between GDM and healthy pregnant women were found at any follow-up time. On the contrary, significant differences in delta AMH values between the first and the second sample (p < 0.0001), the second and the third sample (p < 0.0001), and the first and the third sample (p = 0.004) were found in both groups. The multivariate analysis showed that maternal age was not correlated to delta AMH variations. The analysis of AMH concentrations did not show a significant relationship with body mass index-variation, newborn and placental weight, and GDM, while only maternal age was significantly correlated with AMH concentrations in all blood samples. A significant decrease in AMH values was observed during the third trimester of pregnancy and this was independent on maternal age. GDM does not seem to influence the AMH concentrations during pregnancy and after delivery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25539795     DOI: 10.1007/s12020-014-0515-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

1.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

Authors:  I A J van Rooij; F J M Broekmans; E R te Velde; B C J M Fauser; L F J M M Bancsi; F H de Jong; A P N Themmen
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

2.  AntiMüllerian serum levels during pregnancy.

Authors:  Antonio La Marca; Annibale Volpe
Journal:  Clin Endocrinol (Oxf)       Date:  2006-06       Impact factor: 3.478

3.  Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.

Authors:  Aykut Bayrak; Heather Terbell; Rebecca Urwitz-Lane; Eliran Mor; Frank Z Stanczyk; Richard J Paulson
Journal:  Fertil Steril       Date:  2007-01-16       Impact factor: 7.329

Review 4.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

Review 5.  The Anti-Mullerian hormone and ovarian cancer.

Authors:  Antonio La Marca; Annibale Volpe
Journal:  Hum Reprod Update       Date:  2007-01-09       Impact factor: 15.610

6.  Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study.

Authors:  Benny Almog; Fady Shehata; Sami Suissa; Hananel Holzer; Einat Shalom-Paz; Antonio La Marca; Shanthi Muttukrishna; Andrew Blazar; Richard Hackett; Scott M Nelson; Joao Sabino Cunha-Filho; Talia Eldar-Geva; Ehud J Margalioth; Nick Raine-Fenning; Kannamannadiar Jayaprakasan; Myvanwy McIlveen; Dorothea Wunder; Thomas Freour; Luciano G Nardo; Juan Balasch; Joana Peñarrubia; Jesper Smeenk; Christian Gnoth; Erhard Godehardt; Tsung-Hsien Lee; Maw-Sheng Lee; Ishai Levin; Ronni Gamzu; Togas Tulandi
Journal:  Fertil Steril       Date:  2011-03-31       Impact factor: 7.329

7.  Maternal antimullerian hormone levels do not predict fetal aneuploidy.

Authors:  Beth J Plante; Carmen Beamon; Colleen L Schmitt; Julie S Moldenhauer; Anne Z Steiner
Journal:  J Assist Reprod Genet       Date:  2010-05-20       Impact factor: 3.412

8.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

9.  Anti-Müllerian hormone in pregnant women in relation to other hormones, fetal sex and in circulation of second trimester fetuses.

Authors:  Melissa Lutterodt; Anne Grete Byskov; Sven Oluf Skouby; Ann Tabor; Claus Yding Andersen
Journal:  Reprod Biomed Online       Date:  2009-05       Impact factor: 3.828

Review 10.  Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

Authors:  Laura Pellatt; Suman Rice; Helen D Mason
Journal:  Reproduction       Date:  2010-03-05       Impact factor: 3.906

View more
  3 in total

1.  Exploring the Ovarian Reserve Within Health Parameters: A Latent Class Analysis.

Authors:  Theresa M Hardy; Mauricio Garnier-Villarreal; Donna O McCarthy; Richard A Anderson; Rebecca M Reynolds
Journal:  West J Nurs Res       Date:  2018-08-09       Impact factor: 1.967

2.  A pilot longitudinal study of anti-Müllerian hormone levels throughout gestation in low risk pregnancy.

Authors:  Joshua R Freeman; Brian W Whitcomb; Amrita Roy; Elizabeth R Bertone-Johnson; Nicholas G Reich; Andrew J Healy
Journal:  Health Sci Rep       Date:  2018-06-19

3.  Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study.

Authors:  Michael W Pankhurst; Christine A Clark; Judith Zarek; Carl A Laskin; Ian S McLennan
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.